Press Releases

23andMe Statement Regarding FDA Warning Letter

We have received the warning letter from the Food and Drug Administration. We recognize that we have not met the FDA’s expectations regarding timeline and communication regarding our submission. Our relationship with the FDA is extremely important to us and we are committed to fully engaging with them to address their concerns.

 

 


About 23andMe

23andMe, Inc. is the leading personal genetics company. Founded in 2006, the mission of the company is to help people access, understand and benefit from the human genome. 23andMe has more than one million customers worldwide, with over 80 percent consented to participate in research. 23andMe, Inc. is located in Mountain View, CA. More information is available at www.23andMe.com.

Media Contact(s)

WCG
Kendra Brogden
kbrogden@wcgworld.com
415-658-9765

Tracy Garcia
tgarcia@wcgworld.com
310-862-1334
Return to top